Table 3.

Complete cancer prevalence (cases) in 2018 and 2030 by cancer type^a and years since diagnosis in Italy

Cancer type	Years since diagnosis						Complete prevalence
	<5		5 to <10		≥10
	2018	2030	2018	2030	2018	2030	2018	2030
Alltypesbut skinnon-melanoma	1 136 535	1 092 624	776 609	889 645	1 434 665	2 030 107	3 347 809	4 012 376
Breast	233 971	256 460	183 860	237 447	388 580	559 726	806 411	1 053 633
Prostate	155 815	115 948	132 506	136 565	138 998	307 389	427 319	559 903
Colon–rectum	143 661	112 306	104 532	89 702	174 213	267 248	422 406	469 257
Bladder	102 797	108 199	68 993	73 489	113 377	138 770	285 167	320 458
Thyroid	55 563	53 698	49 709	72 121	85 508	154 969	190 780	280 787
Skin melanoma	56 935	85 389	38 911	59 432	77 368	125 354	173 214	270 175
Non-Hodgkin’s lymphoma	45 606	46 758	33 039	40 433	67 575	102 684	146 220	189 876
Kidney	46 281	53 384	31 628	38 096	59 596	83 210	137 505	174 689
Corpus uteri	34 109	34 666	26 814	34 554	60 782	78 340	121 705	147 560
Lung	56 461	58 571	19 487	28 132	25 911	31 252	101 859	117 956
Testis	11 079	11 743	9808	12 065	32 721	45 234	53 608	69 043

^aCancer types with a prevalence of >200 per 100 000 in 2030 are presented, sorted by the number of prevalent cases.